Skip to content

Splice-Switching Oligonucleotides for Cancer Treatment

Novel and mutation specific approach for targeting the previously “undruggable” RAS oncogenes

Published: 25th June 2019
Splice-Switching Oligonucleotides for Cancer Treatment
Juan Gärtner, stock.adobe.com
Patents
  • Patent family: WO2015091525A1
  • Patent granted in US: US10266828
IP Status
  • Patent application submitted
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Seeking investment